The Global Bacteriophage Therapy Market is expected to foresee a compound annual growth rate of 8.1% from 2021 to 2030.
Phage therapy or bacteriophage therapy uses viruses to treat pathogenic infections. A virus is also known as phages or bacteria eaters. In phage therapy, the virus only attacks the bacteria and is harmless to the host human, plant, or animals. In simple terms, bacteriophages are the natural enemies of bacteria and the virus kills the target bacteria by injecting its genes into the DNA or RNA of the bacteria, causing no harm to other bacteria. Bacteriophages are the most common biological entities of nature and are quite efficient at fighting & destroying drug-resistant bacteria.
Increasing antimicrobial & antibiotic resistance globally, hike in the application of phage therapy among industries such as the food & beverage industry, upsurge in the foodborne diseases globally, and the ongoing extensive R&D are driving the global market of phage therapy. However, phage therapy is still under clinical trials, significant risk of product failure, and company pipelines coupled with the absence of skilled experts, specialists, and professionals are thereby hampering the market growth. In addition, the high cost of bacteriophage therapy is also one of the major factors limiting the worldwide bacteriophage therapy market's growth.
By Region, the global bacteriophage therapy market is segmented into North America, Latin America, Europe, Asia Pacific, and the Rest of the World. Among all the geographies, North America is dominating the market in terms of share owing to factors such as early adoption of new & emerging technologies coupled with expanding volumes of data. However, Asia Pacific is anticipated to witness the highest CAGR During forecast period owing to the increasing patient population and government initiatives to boost the healthcare sector in the region.
The prominent players inducing the Global Bacteriophage Therapy Market are SNIPR BIOME, Armata Pharmaceuticals, Inc. Adaptive Phage Therapeutics, Phagelux, Microgen Russia, BiomX (MBcure Ltd.), Enbiotix, Eligo Bioscience, MicroPhage Inc., Phage International, Intralytix, Inc, InnoPhage, Locus Biosciences, Bitbiome, and PhagoMed Biopharma GmbH, among others.
Segmentation and Scope of the Global Bacteriophage Therapy Market
Global Bacteriophage Therapy Market is segmented by type, target, base, route of administration, application, distribution channel, end-user, and region.
By Route of Administration
By Distribution Channel
Rest of World
Middle East & Africa
Prominent players in the Global Bacteriophage Therapy Market among other includes